Novartis earnings and sales fall short of expectations, but backs 2022 view
October 25, 2022 at 01:34 AM EDT
The Swiss pharma major reported third-quarter net profit of $1.58 billion, on sales which declined to $12.54 billion.
 |
||||||||||||
|
||||||||||||
| About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map | ||||||||||||
Photos copyright by Jay Graham Photographer
